OPZELURA 15 mg/g, crème — 1 tube(s) laminé de 100 g
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930276129 -
CIP7
3027612 -
CIS
68279528 -
Registration number
EU/1/23/1726
What the source publishes
- Holder
- INCYTE BIOSCIENCES DISTRIBUTION (PAYS-BAS)
- Active ingredients
- PHOSPHATE DE RUXOLITINIB, RUXOLITINIB
- Form
- crème
- Package
- 1 tube(s) laminé de 100 g
- Routes
- cutanée
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2023-04-19
- Prescription
- Prescription or restricted
Names this record is found by
- OPZELURA 15 mg/g, crème — 1 tube(s) laminé de 100 g
- OPZELURA 15 mg/g, crème
- PHOSPHATE DE RUXOLITINIB
- RUXOLITINIB
Complete source data
{
"cis": "68279528",
"cip7": "3027612",
"form": "crème",
"name": "OPZELURA 15 mg/g, crème — 1 tube(s) laminé de 100 g",
"cip13": "3400930276129",
"holder": "INCYTE BIOSCIENCES DISTRIBUTION (PAYS-BAS)",
"routes": [
"cutanée"
],
"holders": [
"INCYTE BIOSCIENCES DISTRIBUTION (PAYS-BAS)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "839.41",
"authorisedOn": "2023-04-19",
"compositions": [
{
"name": "PHOSPHATE DE RUXOLITINIB",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "38893",
"dosageReference": null,
"pharmaceuticalElement": "crème"
},
{
"name": "RUXOLITINIB",
"nature": "FT",
"strength": "15 mg",
"linkageNumber": "1",
"substanceCode": "42140",
"dosageReference": "1 g de crème",
"pharmaceuticalElement": "crème"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I",
"dispensingFee": "1.02",
"medicinePrice": "838.39",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "OPZELURA 15 mg/g, crème",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 tube(s) laminé de 100 g",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65 %"
],
"marketingDeclaredOn": "2024-01-31",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"PHOSPHATE DE RUXOLITINIB",
"RUXOLITINIB"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services DERMATOLOGIE",
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/23/1726",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930276129"